Movatterモバイル変換

[0]ホーム
URL:

About:Monoamine reuptake inhibitor

An Entity of Type:drug,from Named Graph:http://dbpedia.org,within Data Space:dbpedia.org

A monoamine reuptake inhibitor (MRI) is a drug that acts as a reuptake inhibitor of one or more of the three major monoamine neurotransmitters serotonin, norepinephrine, and dopamine by blocking the action of one or more of the respective monoamine transporters (MATs), which include the serotonin transporter (SERT), norepinephrine transporter (NET), and dopamine transporter (DAT). This in turn results in an increase in the synaptic concentrations of one or more of these neurotransmitters and therefore an increase in monoaminergic neurotransmission.

PropertyValue
dbo:abstract
  • A monoamine reuptake inhibitor (MRI) is a drug that acts as a reuptake inhibitor of one or more of the three major monoamine neurotransmitters serotonin, norepinephrine, and dopamine by blocking the action of one or more of the respective monoamine transporters (MATs), which include the serotonin transporter (SERT), norepinephrine transporter (NET), and dopamine transporter (DAT). This in turn results in an increase in the synaptic concentrations of one or more of these neurotransmitters and therefore an increase in monoaminergic neurotransmission. (en)
  • 單胺再攝取抑製劑（Monoamine reuptake inhibitor,MRI）[1]是一種藥物，它通過阻斷一種或多種各自的（MATs）的作用，充當三種主要單胺神經遞質—血清素、去甲腎上腺素和多巴胺中一種或多種的再攝取抑制劑，包括5-羥色胺轉運體（SERT）、去甲腎上腺素轉運體（NET）和多巴胺轉運體（DAT）。這進而導致這些神經遞質中一種或多種神經遞質的突觸濃度增加，因此增加。 (zh)
dbo:wikiPageID
  • 35778489 (xsd:integer)
dbo:wikiPageLength
  • 19400 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1098932039 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • A monoamine reuptake inhibitor (MRI) is a drug that acts as a reuptake inhibitor of one or more of the three major monoamine neurotransmitters serotonin, norepinephrine, and dopamine by blocking the action of one or more of the respective monoamine transporters (MATs), which include the serotonin transporter (SERT), norepinephrine transporter (NET), and dopamine transporter (DAT). This in turn results in an increase in the synaptic concentrations of one or more of these neurotransmitters and therefore an increase in monoaminergic neurotransmission. (en)
  • 單胺再攝取抑製劑（Monoamine reuptake inhibitor,MRI）[1]是一種藥物，它通過阻斷一種或多種各自的（MATs）的作用，充當三種主要單胺神經遞質—血清素、去甲腎上腺素和多巴胺中一種或多種的再攝取抑制劑，包括5-羥色胺轉運體（SERT）、去甲腎上腺素轉運體（NET）和多巴胺轉運體（DAT）。這進而導致這些神經遞質中一種或多種神經遞質的突觸濃度增加，因此增加。 (zh)
rdfs:label
  • Monoamine reuptake inhibitor (en)
  • 單胺再攝取抑制劑 (zh)
rdfs:seeAlso
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
isdbo:class of
isdbo:wikiPageDisambiguates of
isdbo:wikiPageRedirects of
isdbo:wikiPageWikiLink of
isdbp:class of
isrdfs:seeAlso of
isfoaf:primaryTopic of
Powered by OpenLink Virtuoso   This material is Open Knowledge    W3C Semantic Web Technology    This material is Open Knowledge   Valid XHTML + RDFa
This content was extracted fromWikipedia and is licensed under theCreative Commons Attribution-ShareAlike 3.0 Unported License
[8]ページ先頭
©2009-2025 Movatter.jp